Exploratory Clinical Trial for Efficacy and Safety of Short-term (3 days) Enoxaparin on Prevention of Venous Thromboembolism after Gastric Cancer Surgery
Phase 2
- Conditions
- Gastric cancer
- Registration Number
- JPRN-UMIN000020235
- Lead Sponsor
- Okayama University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with past history of venous thromboembolism 2) Patients with past history of allergic reaction to heparin or heparinoid (including low molecular weight heparin) 3) Patients with active bleeding (except for bleeding from gastric cancer planned to be resected by surgery) 4) Patients with acute bacterial endocarditis 5) Patients with severe renal dysfunction (Ccr < 30mL/min) 6) Patients with past history of heparin-induced thrombocytopenia 7) Patients who are otherwise judged by the investigator as unsuitable for enrollment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method